Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -370,463 | -240,296 | -104,082 | -288,585 | -204,434 |
| Depreciation Amortization | 1,021 | 2,036 | 541 | 859 | N/A |
| Accounts payable and accrued liabilities | 547 | 3,983 | 4,234 | -4,657 | -3,239 |
| Other Working Capital | -62 | 29,255 | 7,684 | -10,915 | -7,003 |
| Other Operating Activity | 65,504 | 33,253 | 7,703 | 49,711 | 37,292 |
| Operating Cash Flow | $-303,453 | $-171,769 | $-83,920 | $-253,587 | $-177,384 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,225 | -4,676 | -4,477 | -2,638 | -891 |
| Purchase Of Investment | -269,802 | -168,801 | N/A | -212,899 | -197,745 |
| Sale Of Investment | 139,016 | 82,516 | 42,500 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -1,716 | -1,716 |
| Investing Cash Flow | $-136,011 | $-90,961 | $38,023 | $-217,253 | $-200,352 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 550,000 | 550,000 | 550,000 | 36,939 | 19,966 |
| Common Stock Issued | 28,220 | 26,195 | 24,828 | 416,182 | 390,430 |
| Common Stock Repurchased | -124,523 | -124,280 | -124,280 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -997 |
| Other Financing Activity | -11,039 | -12,039 | -11,375 | -54,329 | -53,511 |
| Financing Cash Flow | $442,658 | $439,876 | $439,173 | $398,792 | $355,888 |
| Beginning Cash Position | 364,197 | 364,197 | 364,197 | 436,245 | 436,245 |
| End Cash Position | 367,391 | 541,343 | 757,473 | 364,197 | 414,397 |
| Net Cash Flow | $3,194 | $177,146 | $393,276 | $-72,048 | $-21,848 |
| Free Cash Flow | |||||
| Operating Cash Flow | -303,453 | -171,769 | -83,920 | -253,587 | -177,384 |
| Capital Expenditure | -5,372 | -4,823 | -4,477 | -2,638 | -891 |
| Free Cash Flow | -308,825 | -176,592 | -88,397 | -256,225 | -178,275 |